Skip to content

effect of Fennelin on primary dysmenorrhoea

comparsion of the effect of Fennelin and diclofenac on primary dysmenorrhea

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220512054829N2
Enrollment
100
Registered
2022-10-28
Start date
2022-07-30
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group 1: People take one 30 mg pearl fennelin three times a day after meals with the onset of dysmenorrhea. Each milliliter of this substance contains less than 11.4 mg of

Sponsors

Kashan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 30 Years

Inclusion criteria

Inclusion criteria: Regular menstruation Moderate and severe dysmenorrhea Age between 15-30

Exclusion criteria

Exclusion criteria: People with underlying diseases User of other drugs genital diseases

Design outcomes

Primary

MeasureTime frame
Moderate to severe dysmenorrhoea according to Andresh and Milsom questionnaire. Timepoint: Examination of the severity of dysmenorrhea at the beginning of the study before the intervention and on the 1st, 2nd, 3rd and 4th day of menstruation after the intervention. Method of measurement: Andres and Milsom questionnaire.

Secondary

MeasureTime frame
Nausea with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.;Vomiting with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.;Back pain with dysmenorrhea. Timepoint: At the beginning of drug use and days 1, 2, 3, and 4 of dysmenorrhea in two consecutive menstrual periods. Method of measurement: Andrash and Milsom questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Akbari

Kashan University of Medical Sciences

akbari1350_h@yahoo.com+98 31 5558 9057

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026